Xponance Inc. Boosts Stock Position in KKR & Co. Inc. (NYSE:KKR)

Xponance Inc. raised its stake in shares of KKR & Co. Inc. (NYSE:KKR) by 52.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,896 shares of the asset manager’s stock after buying an additional 36,292 shares during the quarter. Xponance Inc.’s holdings in KKR & Co. Inc. were worth $11,144,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Wellington Management Group LLP grew its position in KKR & Co. Inc. by 219.5% during the 4th quarter. Wellington Management Group LLP now owns 16,206,904 shares of the asset manager’s stock valued at $1,342,742,000 after purchasing an additional 11,134,363 shares during the last quarter. Winslow Capital Management LLC purchased a new stake in shares of KKR & Co. Inc. during the fourth quarter valued at approximately $344,354,000. GQG Partners LLC bought a new stake in shares of KKR & Co. Inc. during the first quarter valued at approximately $217,004,000. Canada Pension Plan Investment Board raised its holdings in KKR & Co. Inc. by 198.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,207,368 shares of the asset manager’s stock worth $337,543,000 after acquiring an additional 2,133,290 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in KKR & Co. Inc. by 4.3% in the 4th quarter. Vanguard Group Inc. now owns 41,670,039 shares of the asset manager’s stock valued at $3,452,363,000 after acquiring an additional 1,728,782 shares in the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

KKR & Co. Inc. Price Performance

NYSE KKR opened at $132.58 on Tuesday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. KKR & Co. Inc. has a 12 month low of $53.72 and a 12 month high of $134.85. The stock has a market cap of $117.65 billion, a price-to-earnings ratio of 29.73, a PEG ratio of 0.99 and a beta of 1.62. The company’s 50 day moving average is $119.21 and its two-hundred day moving average is $108.15.

KKR & Co. Inc. (NYSE:KKR) last released its earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.20. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. The company had revenue of $4.17 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter in the previous year, the company earned $0.58 EPS. As a group, research analysts anticipate that KKR & Co. Inc. will post 4.01 earnings per share for the current year.

KKR & Co. Inc. Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Monday, August 12th were given a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Monday, August 12th. KKR & Co. Inc.’s dividend payout ratio is currently 15.70%.

Insider Buying and Selling

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other KKR & Co. Inc. news, major shareholder Kkr Group Partnership L.P. sold 2,554,644 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $18.85, for a total transaction of $48,155,039.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. The disclosure for this sale can be found here. 39.34% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on KKR. JMP Securities boosted their price target on KKR & Co. Inc. from $115.00 to $135.00 and gave the stock a “market outperform” rating in a research note on Thursday, August 1st. Citigroup upped their target price on shares of KKR & Co. Inc. from $130.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of KKR & Co. Inc. from $128.00 to $141.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Argus upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, StockNews.com raised shares of KKR & Co. Inc. to a “sell” rating in a research report on Saturday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, KKR & Co. Inc. presently has an average rating of “Moderate Buy” and a consensus target price of $128.27.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.